A dynamic control of human telomerase holoenzyme

Human telomerase functions in maintaining genome stability by adding telomeric repeats to the termini of linear chromosomes. Past studies have revealed profound insights into telomerase functions. However, low abundance of functional telomerase and difficulty in quantifying its activity leave partially characterized its thermodynamic and kinetic properties. Using a newly developed method to count individual extension products, we demonstrate that human telomerase holoenzymes contain fast- and slow-acting catalytic sites. Surprisingly, both active sites become inactive after two consecutive rounds of catalysis. The fast active sites turn off ~40-fold quicker than the slow ones and exhibit higher affinity to substrates. In dimeric enzymes, the two sites work in tandem with the faster site functioning before the slower one. In monomeric enzymes, the active sites also perform single-run catalysis. Interestingly, the inactive enzymes can be reactivated by intracellular telomerase-activating factors (iTAFs) available in multiple cell types. Together, the single-run catalysis and the iTAF-triggered reactivation serve as a novel control circuit to ensure that the telomerase holoenzymes are dynamically controlled to match their number of active sites with the number of telomeres they extend. Such exquisite kinetic control of telomerase activity is expected to play important roles in cell division and ageing.

[1]  Eva Nogales,et al.  Cryo-EM structure of substrate-bound human telomerase holoenzyme , 2018, Nature.

[2]  K. Collins,et al.  Telomerase Mechanism of Telomere Synthesis. , 2017, Annual review of biochemistry.

[3]  Michael D. Stone,et al.  Single-Molecule Studies of Telomeres and Telomerase. , 2017, Annual review of biophysics.

[4]  T. Hwang,et al.  Electrostatic tuning of the pre- and post-hydrolytic open states in CFTR , 2017, The Journal of general physiology.

[5]  C. Armstrong,et al.  Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells , 2017, Open Biology.

[6]  B. Dumitriu,et al.  Danazol Treatment for Telomere Diseases. , 2016, The New England journal of medicine.

[7]  A. Yildiz,et al.  Single-molecule imaging of telomerase reverse transcriptase in human telomerase holoenzyme and minimal RNP complexes , 2015, eLife.

[8]  J. Shay,et al.  Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine. , 2015, Cancer discovery.

[9]  H. Amelina,et al.  Telomerase Activation after Recruitment in Fission Yeast , 2014, Current Biology.

[10]  C. Litterst,et al.  Quantitative telomerase enzyme activity determination using droplet digital PCR with single cell resolution , 2014, Nucleic acids research.

[11]  Sara Sandin,et al.  Telomerase structure☆ , 2014, Current opinion in structural biology.

[12]  D. Nesbitt,et al.  Single-Molecule Fluorescence Resonance Energy Transfer Studies of the Human Telomerase RNA Pseudoknot: Temperature-/Urea-Dependent Folding Kinetics and Thermodynamics , 2014, The journal of physical chemistry. B.

[13]  Jennifer A. Doudna,et al.  DNA interrogation by the CRISPR RNA-guided endonuclease Cas9 , 2014, Nature.

[14]  Z. Zhou,et al.  The architecture of Tetrahymena telomerase holoenzyme , 2013, Nature.

[15]  Sara Sandin,et al.  Structure of Active, Dimeric Human Telomerase , 2013, Nature Structural &Molecular Biology.

[16]  Michael D. Stone,et al.  Single-molecule FRET reveals the folding dynamics of the human telomerase RNA pseudoknot domain. , 2012, Angewandte Chemie.

[17]  T. Le Bihan,et al.  Native gel electrophoresis of human telomerase distinguishes active complexes with or without dyskerin , 2011, Nucleic acids research.

[18]  E. Blackburn,et al.  Telomerase: an RNP enzyme synthesizes DNA. , 2011, Cold Spring Harbor perspectives in biology.

[19]  N. Zaffaroni,et al.  Telomeres as targets for anticancer therapies , 2011, Expert opinion on therapeutic targets.

[20]  Michael W. Parker,et al.  Direct involvement of the TEN domain at the active site of human telomerase , 2010, Nucleic acids research.

[21]  O. Dontsova,et al.  Assays for Detection of Telomerase Activity , 2011, Acta naturae.

[22]  L. Montanaro Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer , 2010, The Journal of pathology.

[23]  E. Blackburn Telomeres and telomerase: the means to the end (Nobel lecture). , 2010, Angewandte Chemie.

[24]  K. Elenitoba-Johnson,et al.  A bimolecular affinity purification method under denaturing conditions for rapid isolation of a ubiquitinated protein for mass spectrometry analysis , 2010, Nature Protocols.

[25]  E. Maher,et al.  The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth , 2010, Clinical Cancer Research.

[26]  D. Corey Telomeres and telomerase: from discovery to clinical trials. , 2009, Chemistry & biology.

[27]  Margaret A. Strong,et al.  Short telomeres are sufficient to cause the degenerative defects associated with aging. , 2009, American journal of human genetics.

[28]  T. Lange How Telomeres Solve the End-Protection Problem , 2009 .

[29]  J. Shay,et al.  Telomere Extension Occurs at Most Chromosome Ends and Is Uncoupled from Fill-In in Human Cancer Cells , 2009, Cell.

[30]  D. Shore,et al.  Telomere length regulation: coupling DNA end processing to feedback regulation of telomerase , 2009, The EMBO journal.

[31]  C. Trahan,et al.  Dyskeratosis congenita mutations in the H/ACA domain of human telomerase RNA affect its assembly into a pre-RNP. , 2009, RNA.

[32]  Timothy D. Veenstra,et al.  A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis , 2009, Science.

[33]  C. Greider,et al.  Short Telomeres Initiate Telomere Recombination in Primary and Tumor Cells , 2009, PLoS genetics.

[34]  Wilhelm Palm,et al.  How shelterin protects mammalian telomeres. , 2008, Annual review of genetics.

[35]  D. Shore,et al.  How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex. , 2008, Molecular cell.

[36]  S. Balasubramanian,et al.  Single-molecule analysis of human telomerase monomer. , 2008, Nature chemical biology.

[37]  T. Veenstra,et al.  Identification of ATPases Pontin and Reptin as Telomerase Components Essential for Holoenzyme Assembly , 2008, Cell.

[38]  E. Blackburn,et al.  Telomerase core components protect Candida telomeres from aberrant overhang accumulation , 2007, Proceedings of the National Academy of Sciences.

[39]  N. Bache,et al.  Protein Composition of Catalytically Active Human Telomerase from Immortal Cells , 2007, Science.

[40]  P. Boukamp,et al.  Telomeres rather than telomerase a key target for anti‐cancer therapy? , 2007, Experimental dermatology.

[41]  J. Shay,et al.  Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol , 2006, Nature Protocols.

[42]  E. Blackburn,et al.  Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging , 2006, Nature Medicine.

[43]  T. Cech,et al.  Low abundance of telomerase in yeast: implications for telomerase haploinsufficiency. , 2006, RNA.

[44]  C. Greider Telomerase RNA levels limit the telomere length equilibrium. , 2006, Cold Spring Harbor symposia on quantitative biology.

[45]  T. Lange,et al.  Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .

[46]  J. Lingner,et al.  Telomerase limits the extent of base pairing between template RNA and telomeric DNA , 2005, EMBO reports.

[47]  T. de Lange,et al.  Shelterin: the protein complex that shapes and safeguards human telomeres. , 2005, Genes & development.

[48]  A. Smogorzewska,et al.  Regulation of telomerase by telomeric proteins. , 2004, Annual review of biochemistry.

[49]  T. Cech Beginning to Understand the End of the Chromosome , 2004, Cell.

[50]  P. Baumann,et al.  DNA self-recognition in the structure of Pot1 bound to telomeric single-stranded DNA , 2003, Nature.

[51]  J. Shay,et al.  Novel Short Oligonucleotide Conjugates as Inhibitors of Human Telomerase , 2003, Nucleosides, nucleotides & nucleic acids.

[52]  K. Pongracz,et al.  Interaction of human telomerase with its primer substrate. , 2003, Biochemistry.

[53]  Fred J Sigworth,et al.  Three‐dimensional structure of the type 1 inositol 1,4,5‐trisphosphate receptor at 24 Å resolution , 2002, The EMBO journal.

[54]  Margaret A. Strong,et al.  The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability , 2001, Cell.

[55]  E. Blackburn Switching and Signaling at the Telomere , 2001, Cell.

[56]  M. Amacker,et al.  Human telomerase contains two cooperating telomerase RNA molecules , 2001, The EMBO journal.

[57]  E. Blackburn,et al.  Telomere states and cell fates , 2000, Nature.

[58]  J. Shay,et al.  Transient expression of human telomerase extends the life span of normal human fibroblasts. , 2000, Biochemical and biophysical research communications.

[59]  E. Blackburn Telomeres and telomerase. , 2000, The Keio journal of medicine.

[60]  Heidi S. Liss,et al.  Subsenescent Telomere Lengths in Fibroblasts Immortalized by Limiting Amounts of Telomerase* , 2000, The Journal of Biological Chemistry.

[61]  M. Seldin,et al.  Telomere length regulation in mice is linked to a novel chromosome locus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Robinson,et al.  Reconstitution of human telomerase activity in vitro , 1998, Current Biology.

[63]  E. Blackburn,et al.  Functionally interacting telomerase RNAs in the yeast telomerase complex. , 1997, Genes & development.

[64]  D. Shore,et al.  A Protein-Counting Mechanism for Telomere Length Regulation in Yeast , 1997, Science.